Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of BRM421 for Dry Eye Syndrome
Sponsor: BRIM Biotechnology Inc.
Summary
The objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Official title: A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
157
Start Date
2017-02-07
Completion Date
2017-06-28
Last Updated
2026-05-01
Healthy Volunteers
No
Conditions
Interventions
BRM421
0.03%(w/v) BRIM421 ophthalmic solution
Placebo
vehicle ophthalmic drops
Locations (2)
Central Maine Eye Care
Lewiston, Maine, United States
Andover Eye Associates
Andover, Massachusetts, United States